What You Need to Know About Johnson & Johnson's 2020 First-Quarter Earnings
Have Questions About Participating in a COVID-19 Vaccine Clinical Trial? A Doctor Overseeing a Study Helps Answer ThemDid you like reading this story? Click the heart to show your love.
Johnson & Johnson Joins Other Companies in Signing a Landmark Communiqué on Expanded Global Access for COVID-19Did you enjoy reading this story? Click the heart.
Did you like taking this quiz? Click the heart to show your love.
This morning, Johnson & Johnson shared its first-quarter performance.
Since its founding in 1886, the company has grown to become one of the world's largest and most broadly based healthcare companies, with approximately 132,000 employees across the globe working every day to help change the trajectory of health for humanity.
“We recognize the unfortunate impact that the COVID-19 pandemic has had on people, communities, businesses and the world. While Johnson & Johnson’s first quarter results were strong, reflecting the resiliency of our diversified business, that narrative has understandably taken a back seat to the more pressing concern of addressing COVID-19,” says , Executive Vice President, Chief Financial Officer. “We are not only confident in winning the fight against this public health crisis with efforts such as our collaboration to co-fund investment in vaccine development, but we also have confidence in the fundamentals of our entire business, which are remarkably strong for the long term.”
For more details about the company's 2020 first-quarter results, and to read a message from Chairman and Chief Executive Officer, here's an infographic that highlights key stats.
Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.